March 25, 2025 - 20:29

BEAVERTON, Ore., March 25, 2025—In a groundbreaking development for the advertising industry, Datavault AI has officially licensed its patented ADIO technology to NYIAX. This partnership is set to transform the landscape of ultrasonic advertising, promising a new era of innovative marketing solutions.
The ADIO technology, which stands for Audio Digital Interactive Overlay, allows advertisers to deliver targeted messages directly to consumers' devices using ultrasonic frequencies. This method bypasses traditional advertising barriers, enabling brands to engage with audiences in a more personalized and effective manner. By utilizing sound waves that are inaudible to the human ear, the technology ensures that advertisements can be delivered seamlessly without disrupting the consumer experience.
NYIAX, known for its cutting-edge advertising solutions, is poised to integrate this technology into its platform, enhancing its capabilities and providing clients with unique advertising opportunities. Both companies anticipate that this collaboration will not only elevate brand engagement but also set a new standard in the advertising domain, paving the way for future innovations.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...